BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 15323185)

  • 21. Role of the Maillard reaction in diabetes mellitus and diseases of aging.
    Thorpe SR; Baynes JW
    Drugs Aging; 1996 Aug; 9(2):69-77. PubMed ID: 8820792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation end product (age) inhibitors and their therapeutic implications in diseases.
    Takeuchi M; Yamagishi S; Iwaki M; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2004; 24(2-3):95-101. PubMed ID: 15689055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification.
    Schalkwijk CG; Stehouwer CD; van Hinsbergh VW
    Diabetes Metab Res Rev; 2004; 20(5):369-82. PubMed ID: 15343583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases.
    Reddy VP; Beyaz A
    Drug Discov Today; 2006 Jul; 11(13-14):646-54. PubMed ID: 16793534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of the Maillard reaction on the physical properties and cell interactions of collagen.
    Avery NC; Bailey AJ
    Pathol Biol (Paris); 2006 Sep; 54(7):387-95. PubMed ID: 16962252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The AGE of the matrix: chemistry, consequence and cure.
    DeGroot J
    Curr Opin Pharmacol; 2004 Jun; 4(3):301-5. PubMed ID: 15140424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
    Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
    Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes.
    Rojas A; Morales MA
    Life Sci; 2004 Dec; 76(7):715-30. PubMed ID: 15581904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycated proteins in diabetes.
    Furth AJ
    Br J Biomed Sci; 1997 Sep; 54(3):192-200. PubMed ID: 9499597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid glycation and protein glycation in diabetes and atherosclerosis.
    Miyazawa T; Nakagawa K; Shimasaki S; Nagai R
    Amino Acids; 2012 Apr; 42(4):1163-70. PubMed ID: 20957396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(6):1013-5. PubMed ID: 16146671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods.
    Henle T
    Amino Acids; 2005 Dec; 29(4):313-22. PubMed ID: 15997413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Proteins modified in the nonenzymatically glycosylation reaction (AGE-proteins)--new markers for diabetes?].
    Zdrojewicz Z; Januszewski A; Kwiatkowska D
    Postepy Hig Med Dosw; 1994; 48(6):689-700. PubMed ID: 7675730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the amadori product in the complications of diabetes.
    Monnier VM; Sell DR; Dai Z; Nemet I; Collard F; Zhang J
    Ann N Y Acad Sci; 2008 Apr; 1126():81-8. PubMed ID: 18448799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
    Khalifah RG; Baynes JW; Hudson BG
    Biochem Biophys Res Commun; 1999 Apr; 257(2):251-8. PubMed ID: 10198198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-specific synthesis of Amadori-modified peptides on solid phase.
    Frolov A; Singer D; Hoffmann R
    J Pept Sci; 2006 Jun; 12(6):389-95. PubMed ID: 16342332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update.
    Lapolla A; Fedele D; Seraglia R; Traldi P
    Mass Spectrom Rev; 2006; 25(5):775-97. PubMed ID: 16625652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward a Maillard reaction theory of aging.
    Monnier VM
    Prog Clin Biol Res; 1989; 304():1-22. PubMed ID: 2675024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue distribution of albumin-glucose advanced glycation end products administrated to chickens.
    Kita K
    Anim Sci J; 2011 Apr; 82(2):291-5. PubMed ID: 21729208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T; Kato Y
    Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.